These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 8642292

  • 1. Inactivation of human immunodeficiency virus (HIV)-1 envelope-specific CD8+ cytotoxic T lymphocytes by free antigenic peptide: a self-veto mechanism?
    Takahashi H, Nakagawa Y, Leggatt GR, Ishida Y, Saito T, Yokomuro K, Berzofsky JA.
    J Exp Med; 1996 Mar 01; 183(3):879-89. PubMed ID: 8642292
    [Abstract] [Full Text] [Related]

  • 2. Preferential V beta usage by cytotoxic T cells cross-reactive between two epitopes of HIV-1 gp160 and degenerate in class I MHC restriction.
    Shirai M, Vacchio MS, Hodes RJ, Berzofsky JA.
    J Immunol; 1993 Aug 15; 151(4):2283-95. PubMed ID: 7688397
    [Abstract] [Full Text] [Related]

  • 3. Broad recognition of cytotoxic T cell epitopes from the HIV-1 envelope protein with multiple class I histocompatibility molecules.
    Shirai M, Pendleton CD, Berzofsky JA.
    J Immunol; 1992 Mar 15; 148(6):1657-67. PubMed ID: 1371784
    [Abstract] [Full Text] [Related]

  • 4. Structural requirements for class I MHC molecule-mediated antigen presentation and cytotoxic T cell recognition of an immunodominant determinant of the human immunodeficiency virus envelope protein.
    Takahashi H, Houghten R, Putney SD, Margulies DH, Moss B, Germain RN, Berzofsky JA.
    J Exp Med; 1989 Dec 01; 170(6):2023-35. PubMed ID: 2479705
    [Abstract] [Full Text] [Related]

  • 5. Brucella abortus conjugated with a peptide derived from the V3 loop of human immunodeficiency virus (HIV) type 1 induces HIV-specific cytotoxic T-cell responses in normal and in CD4+ cell-depleted BALB/c mice.
    Lapham C, Golding B, Inman J, Blackburn R, Manischewitz J, Highet P, Golding H.
    J Virol; 1996 May 01; 70(5):3084-92. PubMed ID: 8627787
    [Abstract] [Full Text] [Related]

  • 6. Role of conserved regions of class I MHC molecules in the activation of CD8+ cytotoxic T lymphocytes by peptide and purified cell-free class I molecules.
    Takeshita T, Kozlowski S, England RD, Brower R, Schneck J, Takahashi H, DeLisi C, Margulies DH, Berzofsky JA.
    Int Immunol; 1993 Sep 01; 5(9):1129-38. PubMed ID: 8241055
    [Abstract] [Full Text] [Related]

  • 7. Induction of CD8+ cytotoxic T lymphocytes by immunization with syngeneic irradiated HIV-1 envelope derived peptide-pulsed dendritic cells.
    Takahashi H, Nakagawa Y, Yokomuro K, Berzofsky JA.
    Int Immunol; 1993 Aug 01; 5(8):849-57. PubMed ID: 8398980
    [Abstract] [Full Text] [Related]

  • 8. Characterization of the Fas ligand/Fas-dependent apoptosis of antiretroviral, class I MHC tetramer-defined, CD8+ CTL by in vivo retrovirus-infected cells.
    Rich RF, Green WR.
    J Immunol; 2002 Mar 15; 168(6):2751-8. PubMed ID: 11884442
    [Abstract] [Full Text] [Related]

  • 9. Cytotoxic T cell repertoire selection. A single amino acid determines alternative class I restriction.
    Bergmann CC, Tong L, Cua RV, Sensintaffar JL, Stohlman SA.
    J Immunol; 1994 Jun 15; 152(12):5603-12. PubMed ID: 7515908
    [Abstract] [Full Text] [Related]

  • 10. An immunodominant class I-restricted cytotoxic T lymphocyte determinant of human immunodeficiency virus type 1 induces CD4 class II-restricted help for itself.
    Takahashi H, Germain RN, Moss B, Berzofsky JA.
    J Exp Med; 1990 Feb 01; 171(2):571-6. PubMed ID: 1689366
    [Abstract] [Full Text] [Related]

  • 11. Induction of rapid apoptosis for class I MHC molecule-restricted CD8(+) HIV-1 gp160-specific murine activated CTLs by free antigenic peptide in vivo.
    Nakagawa Y, Shimizu M, Norose Y, Takahashi M, Takahashi H.
    Int Immunol; 2013 Jan 01; 25(1):11-24. PubMed ID: 22945875
    [Abstract] [Full Text] [Related]

  • 12. Induction of a major histocompatibility complex class I-restricted cytotoxic T-lymphocyte response to a highly conserved region of human immunodeficiency virus type 1 (HIV-1) gp120 in seronegative humans immunized with a candidate HIV-1 vaccine.
    Johnson RP, Hammond SA, Trocha A, Siliciano RF, Walker BD.
    J Virol; 1994 May 01; 68(5):3145-53. PubMed ID: 7908700
    [Abstract] [Full Text] [Related]

  • 13. Self-veto mechanism of CD8+ cytotoxic effector T cells. Peptide-induced paralysis affects the peptide-MHC-recognizing cytotoxic T lymphocytes and is independent of Fas/Fas ligand interactions.
    Bergenthal A, Hofmann M, Heeg K.
    Eur J Immunol; 1998 Jun 01; 28(6):1911-22. PubMed ID: 9645373
    [Abstract] [Full Text] [Related]

  • 14. Helper-cytotoxic T lymphocyte (CTL) determinant linkage required for priming of anti-HIV CD8+ CTL in vivo with peptide vaccine constructs.
    Shirai M, Pendleton CD, Ahlers J, Takeshita T, Newman M, Berzofsky JA.
    J Immunol; 1994 Jan 15; 152(2):549-56. PubMed ID: 8283036
    [Abstract] [Full Text] [Related]

  • 15. Cytotoxic T lymphocytes specific for HIV-1 gp160 antigen and synthetic P18IIIB peptide in an HLA-A11-immunized individual.
    Achour A, Lemhammedi S, Picard O, M'Bika JP, Zagury JF, Moukrim Z, Willer A, Beix F, Burny A, Zagury D.
    AIDS Res Hum Retroviruses; 1994 Jan 15; 10(1):19-25. PubMed ID: 8179960
    [Abstract] [Full Text] [Related]

  • 16. An endogenously synthesized decamer peptide efficiently primes cytotoxic T cells specific for the HIV-1 envelope glycoprotein.
    Bergmann C, Stohlmann SA, McMillan M.
    Eur J Immunol; 1993 Nov 15; 23(11):2777-81. PubMed ID: 7693478
    [Abstract] [Full Text] [Related]

  • 17. Counter-regulation of cytolytic activity and cytokine production in HIV-1-specific murine CD8+ cytotoxic T lymphocytes by free antigenic peptide.
    Takahashi M, Nakagawa Y, Berzofsky JA, Takahashi H.
    Int Immunol; 2001 Jan 15; 13(1):43-51. PubMed ID: 11133833
    [Abstract] [Full Text] [Related]

  • 18. Analysis of the mechanism for extracellular processing in the presentation of human immunodeficiency virus-1 envelope protein-derived peptide to epitope-specific cytotoxic T lymphocytes.
    Nakagawa Y, Takeshita T, Berzofsky JA, Takahashi H.
    Immunology; 2000 Sep 15; 101(1):76-82. PubMed ID: 11012756
    [Abstract] [Full Text] [Related]

  • 19. Identification of overlapping HLA class I-restricted cytotoxic T cell epitopes in a conserved region of the human immunodeficiency virus type 1 envelope glycoprotein: definition of minimum epitopes and analysis of the effects of sequence variation.
    Johnson RP, Trocha A, Buchanan TM, Walker BD.
    J Exp Med; 1992 Apr 01; 175(4):961-71. PubMed ID: 1372650
    [Abstract] [Full Text] [Related]

  • 20. Production of transmembrane and secreted forms of tumor necrosis factor (TNF)-alpha by HIV-1-specific CD4+ cytolytic T lymphocyte clones. Evidence for a TNF-alpha-independent cytolytic mechanism.
    Liu AY, Miskovsky EP, Stanhope PE, Siliciano RF.
    J Immunol; 1992 Jun 15; 148(12):3789-98. PubMed ID: 1351088
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.